A large nationally representative study of 3,830 middle-aged and older Korean adults found that people eating the most magnesium, and people eating the most magnesium-rich plant foods, had roughly half the odds of sarcopenia (age-related muscle loss and weakness) compared with those eating the least. The link held after adjusting for protein intake, overall diet quality, and vitamin D. Part of the benefit appeared to travel through lower chronic inflammation, measured by the blood marker hsCRP. Because this is observational and cross-sectional, it can show association but not prove that magnesium causes stronger muscles.
Sarcopenia, the slow erosion of muscle mass and strength with age, has no approved drug and few nutritional levers beyond the familiar two: protein and vitamin D. A new analysis published in Frontiers in Nutrition on 3 August 2026 argues that a third lever, dietary magnesium, has been hiding in plain sight.
Researchers Sooyeun Choi and Youjin Je of Kyung Hee University in Seoul drew on the Korea National Health and Nutrition Examination Survey, a rolling government health survey. From roughly 20,000 participants they carved out 3,830 adults aged 50 and older with complete data, excluding people with major chronic diseases that could confuse the picture. They then measured magnesium intake two ways. The first was straightforward daily magnesium in milligrams. The second was a magnesium-rich diet score that rewarded eating from five plant food groups: whole grains, nuts and legumes, green leafy vegetables and seaweeds, soymilk, and coffee.
The pattern was consistent. Adults in the top quarter of magnesium intake had 53 percent lower odds of sarcopenia than those in the bottom quarter. Those with the highest magnesium-rich diet score had 50 percent lower odds. The relationship was graded rather than all-or-nothing: every extra 100 milligrams of magnesium per day tracked with about 26 percent lower odds of sarcopenia, and the associations survived heavy statistical adjustment for age, sex, body size, kidney function, physical activity, smoking, income, education, protein intake, total calories, and overall diet quality.
The more provocative claim concerns mechanism. The authors used mediation analysis to ask whether magnesium works partly by cooling chronic inflammation. High-sensitivity C-reactive protein, a downstream marker of that inflammation, accounted for a modest slice of the benefit: about 7 percent of magnesium’s link to muscle mass, and 18 percent of the diet score’s link to muscle mass. In plain terms, inflammation is part of the story but far from the whole story. Magnesium also feeds muscle through protein synthesis signaling, energy metabolism, and mitochondrial function.
The authors are careful. A single day’s diet recall is a blurry snapshot, and cross-sectional data cannot establish that muscle followed magnesium rather than the reverse. But they note something striking from prior work: in a UK Biobank analysis, magnesium showed a larger association with grip strength than any other macro or micronutrient, and one British study found magnesium’s tie to muscle mass three to seven times stronger than protein’s. If even a fraction of that is causal, current guidelines that mention only protein and vitamin D may be missing the mineral.
Actionable insights
The practical message is simple: eat more magnesium-rich plant foods, and you may be doing your aging muscles a favor beyond what protein alone provides. The foods that drove the benefit are ordinary and cheap: whole grains, nuts and legumes, leafy greens and seaweed, soymilk, and coffee. The target contrast in this study was real-world achievable. The gap between the lowest and highest magnesium eaters was about 270 mg per day for women and 320 mg per day for men, which is roughly the difference between a refined-carb diet and one built around the foods above.
How big is the effect? The honest answer is moderate, not miraculous. Converting the study’s odds ratios to a standardized effect size (Cohen’s d), the top-versus-bottom magnesium comparison for sarcopenia corresponds to about d = 0.42, and the diet score to about d = 0.38. Both sit in the small-to-moderate range. Put differently, moving from the bottom to the top of the magnesium distribution was associated with roughly halving the odds of sarcopenia (odds ratio around 0.47 to 0.50). Because sarcopenia was uncommon here (about 9 percent in the lowest-intake group), that odds ratio is close to a genuine halving of risk.
The catch worth stating plainly: this is association, not proof. The one randomized trial of magnesium alone (a supplement, not food) found no muscle benefit. So the realistic take-home is dietary, not pharmacological. Build meals around magnesium-rich whole plant foods as a low-risk habit that also improves overall diet quality, rather than reaching for a magnesium pill expecting a muscle payoff.
Context and source
- Open access paper: Associations of magnesium intake and a magnesium-rich diet score with sarcopenia in middle-aged and older Korean adults: potential mediation by C-reactive protein.
- Authors and institution: Sooyeun Choi and Youjin Je, Department of Food and Nutrition, Kyung Hee University, Seoul, Republic of Korea.
- Journal: Frontiers in Nutrition. Published 3 August 2026.
- Impact evaluation: Frontiers in Nutrition carries a 2024 Journal Impact Factor of about 5.5 (Clarivate JCR, Q1 in Nutrition and Dietetics), with a Scopus CiteScore in the range of roughly 5 to 8 depending on source and year. Using the JIF: the impact score of this journal is 5.5, evaluated against a typical high-end range of 0 to 60+ for top general science and top specialty journals, therefore this is a Medium impact journal.
LaraPo